ULTRAGENYX PHARMACEUTICAL INC. Other Current Assets
ULTRAGENYX PHARMACEUTICAL INC. (RARE) had Other Current Assets of $41.37 million as of 2024-09-30, per its 10-Q filed 2024-11-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2024-11-06
- 2024-09-30: Other Assets, Current $41.37M.
- 2024-06-30: Other Assets, Current $54.70M.
- 2024-03-31: Other Assets, Current $47.73M.
- 2023-12-31: Other Assets, Current $47.62M.
| Period end | Other Assets, Current |
|---|---|
| 2024-09-30 | $41.37M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $54.70M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $47.73M 10-Q · filed 2024-05-03 |
| 2023-12-31 | $47.62M 10-Q · filed 2024-11-06 |
| 2022-12-31 | $68.93M 10-K · filed 2024-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |